Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kadar Moideen

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Cytokine|September 1, 2019
Heterogeneity in the cytokine profile of tuberculosis - diabetes co-morbidityNathella P Kumar, Kadar Moideen, Arul Nancy, et al.
Frontiers in Nutrition|June 16, 2023
Low body mass index is associated with diminished plasma cytokines and chemokines in both active and latent tuberculosisNathella Pavan Kumar, Arul P Nancy, Kadar Moideen, et al.
The Journal of Infectious Diseases|April 21, 2020
Strongyloides stercoralis Coinfection Is Associated With Greater Disease Severity, Higher Bacterial Burden, and Elevated Plasma Matrix Metalloproteinases in Pulmonary TuberculosisNathella P Kumar, Gokul R Kathamuthu, Kadar Moideen, et al.
Cytokine|June 5, 2023
Plasma Vitamin D levels in correlation with circulatory proteins could be a potential biomarker tool for pulmonary tuberculosis and treatment monitoringKadar Moideen, Pavan Kumar Nathella, Seshacharyulu Madabushi, et al.
Immunology|November 15, 2018
Elevated circulating levels of monocyte activation markers among tuberculosis patients with diabetes co-morbidityNathella P Kumar, Kadar Moideen, Yukthi Bhootra, et al.
Pathogens (Basel, Switzerland)|February 26, 2025
Association of Altered Baseline Hematological Parameters with Adverse Tuberculosis Treatment OutcomesArul Nancy Pandiarajan, Nathella Pavan Kumar, Kadar Moideen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2020
Plasma Chemokines Are Baseline Predictors of Unfavorable Treatment Outcomes in Pulmonary TuberculosisNathella P Kumar, Kadar Moideen, Arul Nancy, et al.
JAMA Network Open|December 1, 2020
Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary TuberculosisNathella P Kumar, Kadar Moideen, Arul Nancy, et al.
Open Forum Infectious Diseases|March 12, 2025
Impact of <i>Strongyloides stercoralis</i> Coinfection on Disease Severity and Treatment Outcomes in Pulmonary TuberculosisNathella Pavan Kumar, Saravanan Munisankar, Bindu Dasan, et al.
Frontiers in Immunology|October 6, 2025
Impact of cytomegalovirus exposure on disease severity, bacterial burden, immune responses and treatment outcomes in tuberculosisBindu Dasan, Saravanan Munisankar, Nathella Pavan Kumar, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Cytokine|September 1, 2019
Heterogeneity in the cytokine profile of tuberculosis - diabetes co-morbidityNathella P Kumar, Kadar Moideen, Arul Nancy, et al.
Frontiers in Nutrition|June 16, 2023
Low body mass index is associated with diminished plasma cytokines and chemokines in both active and latent tuberculosisNathella Pavan Kumar, Arul P Nancy, Kadar Moideen, et al.
The Journal of Infectious Diseases|April 21, 2020
Strongyloides stercoralis Coinfection Is Associated With Greater Disease Severity, Higher Bacterial Burden, and Elevated Plasma Matrix Metalloproteinases in Pulmonary TuberculosisNathella P Kumar, Gokul R Kathamuthu, Kadar Moideen, et al.
Cytokine|June 5, 2023
Plasma Vitamin D levels in correlation with circulatory proteins could be a potential biomarker tool for pulmonary tuberculosis and treatment monitoringKadar Moideen, Pavan Kumar Nathella, Seshacharyulu Madabushi, et al.
Immunology|November 15, 2018
Elevated circulating levels of monocyte activation markers among tuberculosis patients with diabetes co-morbidityNathella P Kumar, Kadar Moideen, Yukthi Bhootra, et al.
Pathogens (Basel, Switzerland)|February 26, 2025
Association of Altered Baseline Hematological Parameters with Adverse Tuberculosis Treatment OutcomesArul Nancy Pandiarajan, Nathella Pavan Kumar, Kadar Moideen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2020
Plasma Chemokines Are Baseline Predictors of Unfavorable Treatment Outcomes in Pulmonary TuberculosisNathella P Kumar, Kadar Moideen, Arul Nancy, et al.
JAMA Network Open|December 1, 2020
Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary TuberculosisNathella P Kumar, Kadar Moideen, Arul Nancy, et al.
Open Forum Infectious Diseases|March 12, 2025
Impact of <i>Strongyloides stercoralis</i> Coinfection on Disease Severity and Treatment Outcomes in Pulmonary TuberculosisNathella Pavan Kumar, Saravanan Munisankar, Bindu Dasan, et al.
Frontiers in Immunology|October 6, 2025
Impact of cytomegalovirus exposure on disease severity, bacterial burden, immune responses and treatment outcomes in tuberculosisBindu Dasan, Saravanan Munisankar, Nathella Pavan Kumar, et al.
Pageof 6